Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience.
Espigado
I
I
Spanish Hemopoyetic Transplant Group (GETH), Hospital Virgen del Rocío, Sevilla, Spain.
Marín-Niebla
A
A
Rovira
M
M
Juliá
A
A
Rodríguez
J M
JM
Altés
A
A
Arranz
R
R
Bargay
J
J
Diez
J L
JL
Forés
R
R
Morales
A
A
Graus
F
F
Messague
I
I
Hernández
J C
JC
Parody
R
R
Richard
C
C
Ferrá
C
C
García
A
A
Carreras
E
E
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001327:Autoimmune Diseases / Q000628:therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy; D011994:Recombinant Proteins; D013030:Spain; D033581:Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods* / Q000401:mortality; D019172:Transplantation Conditioning / Q000379:methods
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor